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OBJECTIVE: To determine if there is a correlation between the BODE Index and variables assessed during the Activities of 
Daily Living assessment, performance on lower limber tests, and peripheral muscle impairment of the upper limb in patients with 
chronic obstructive pulmonary disease. 
MATERIALS AND METHODS: Ten men (aged 58 to 80 years old) with moderate to very severe obstruction were evaluated and 
classified by the BODE Index. They were evaluated by pulmonary ventilation (V
•
E), oxygen consumption (V
•
O2), and carbonic gas 
production (V
•
CO2) on the ADL assessment; Distance Walking (DW) in the Six Minute Walking Test (6MWT) and the Six Minute 
Walking Test on Treadmill (6MWTT); number of repetitions in the Sit-to-Stand Test; and the Hand Grip Strength Test. Correlations 
were evaluated between the classification and the tests performed (Pearson and Spearman test, p<0.05). 
RESULTS: The mean of the total score for the BODE Index was 2.80 (±1.03), with three patients scoring in the first quartile (Q1) 
and seven scoring in the second quartile (Q2). This Index showed a negative correlation with the 6MWTT (r=-0.86), the Sit-to-Stand 
Test (r=-0.66), and the Hand Grip Strength Test (r=-0.83). 
CONCLUSIONS: Our results show that there is no correlation between the BODE Index and the ventilatory and metabolic re-
sponses in the Activities of Daily Living assessment. On the other hand, a correlation was observed between the BODE Index and 
the variables assessed in the 6MWTT, Sit-to-Stand Test, and Hand Grip Strength Test in moderate to very severe Chronic Obstructive 
Pulmonary Disease patients. This suggests that these tests can be employed as predictors of physical exercise capacity, perhaps as 
complementary tests to the BODE Index. 
KEYWORDS: Respiratory Physiotherapy; Activities of Daily Living; Six Minute Walk Test; Sit-to-Stand Test; Hand Grip Strength.
INTRODUCTION 
Chronic Obstructive Pulmonary Disease (COPD) is 
characterized by ventilatory, metabolic, and peripheral 
muscle limitation, dyspnea1,2 and reduced exercise capacity. 
These condition decrease functional capacity,3 compromising 
the performance of Activities of Daily Living (ADL) 
due to a reduction in ventilatory and metabolic reserves.4 
These limitations may be related to significant weight 
loss,5 respiratory muscle weakness,6 reduced strength and 
endurance of the upper (UL) and lower limbs (LL),7 higher 
mortality, and a worsened overall quality of life. Thus, 
COPD is considered as a systemic disease, affecting not only 
the lungs, but also a number of other organs, including the 
peripheral musculature.
The ability to exert physical effort independently 
influences the survival of these patients, and, due to the 
seriousness of these changes, the mortality risk for patients 
with COPD can be assessed by the BODE Index (B - Body 
mass index; O - airflow Obstruction; D – Dyspnea; and E - 
Exercise capacity), which is considered the best predictor 
of survival in these patients.8 For the BODE Index, exercise 
capacity is verified by the distance walked in the Six Minute 984
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Walking Test in a hallway (6MWT). Due to the impairments 
associated with COPD, however, exercise capacity must also 
be verified by other tests, such as the performance of ADL 
that require elevation of the UL and LL, the Six Minute 
Walking Test on a Treadmill (6MWTT),9 the Sit-to-Stand 
Test (STST),10 and the Hand Grip Strength Test (HGT),11 in 
order to determine the survival and general state of health of 
these patients.
ADL are defined as tasks that individuals perform 
on a daily basis, such as dressing, eating, bathing, 
combing hair, sitting down, and moving from one place 
to another.12 Both the UL and the LL are involved in the 
most common ADL. The muscles that participate in the 
positioning of the UL, such as the trapezius, pectoralis 
minor, scalene, sternocleidomastoid, and intercostals, also 
perform ventilatory and postural functions.13 Therefore, the 
performance of ADL tests as part of the routine evaluation of 
patients with respiratory functions is indispensable.
The LL tests selected for our study are considered to 
be good functional evaluation predictors14,10 because they 
evaluate, even if indirectly, the musculature of the LL, which 
is debilitated in patients with COPD. Peripheral muscle 
strength of the hand and UL have been assessed by hand 
grip strength, which constitutes a relevant indicator in the 
analysis of the general state of strength in an individual11 and 
is essential for the performance of ADL.
No reports have correlated ventilatory and metabolic 
variables and the muscle strength of the UL to the BODE 
Index during the performance of ADL and LL and UL tests. 
Furthermore, no studies have addressed whether or not there 
is a relationship between the performance of these tests and 
the BODE Index. 
The present study aimed to determine whether there is 
a correlation between the BODE Index and the variables 
evaluated during ADL assessment, in addition to LL and 
UL tests such as 6MWTT, STST, and HGT, in patients with 
COPD. We hypothesized that there would be a correlation 
between the BODE Index and the ventilatory and metabolic 
responses during the performance of ADL and LL tests, the 
variables assessed in LL tests, and muscle strength of the 
UL.
MATERIALS AND METHODS
For the present study, a cross-sectional design and a non-
probabilistic method were used. The power was calculated 
using the standard deviation and the mean difference in 
the principal variables of the BODE Index described in a 
previous pilot study.
This study was conducted in the Special Respiratory 
Physiotherapy Unit of the Institution. Initially, 12 men with 
moderate to very severe obstruction14, aged from 58 to 80 
years old, were evaluated. 
Ten patients completed the evaluations (five with 
moderate COPD, three with severe COPD, and two with 
very severe COPD).14 Among these patients, ten used a 
bronchodilator (BD) exclusively and seven used a BD and a 
prescription corticosteroid. 
In accordance with the Brazilian National Health 
Council, ethics approval was obtained from the Ethics 
Committee of the Institution (no 46/2007) and all patients 
provided written informed consent. 
Inclusion and Exclusion Criteria
We included males with a clinical diagnosis of COPD 
confirmed by post-BD spirometry administered by a 
pneumologist, in accordance with the GOLD criteria, 
who were classified as having moderate to very severe 
obstruction.15 Moreover, the subjects were clinically stable 
and had no history of infection and no exacerbation of 
respiratory symptoms or changes in medication for at least 
two months before the study. Additionally, the subjects 
did not present with cardiac, rheumatic, or an associated 
orthopedic disease that would impede them from performing 
the proposed evaluation tasks, and all were ex- or non-
smokers. 
Patients were excluded from the study when the type 
of medication was modified during the study, in cases of 
uncontrolled arterial hypertension or hypoxemia (peripheral 
oxygen saturation [SpO2]) below 85% at rest), or for refusal 
to provide written informed consent. 
Measurements
All patients answered a questionnaire related to their 
physical activity routine, namely, the Modified Baecke 
Questionnaire, which includes an evaluation of habitual 
physical activity in the elderly (MBQ),16,17 given that the 
majority of patients were elderly (80%).18
The patients with COPD were sent to the Respiratory 
Physiotherapy Service at the institution, where they 
underwent general physical and specific respiratory exams 
and were informed of the proposed protocols. 
The complete evaluation was carried out on four 
separate days: an initial evaluation, administration of the 
questionnaires, and anthropometric evaluation took place 
on the first day; the 6MWT and the 6MWTT, with a rest 
interval of 30 min between them, were administered on the 
second day; the HGT was given on the third day; and the 
ADL Test, including the STST, was administered on the 
fourth day. 985
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BODE Index
The BODE Index Score, which varies from zero to ten, 
was calculated for each individual by summing the points 
for each variable: BMI, FEV1, dyspnea according to the 
Medical Research Council Dyspnea Scale (MRC), and 
distance walked (DW) in the 6MWT. Score classification 
was divided into quartiles: quartile 1 (Q1), from 0 to 2 
points; quartile 2 (Q2), from 3 to 4 points; quartile 3 (Q3), 
from 5 to 6 points; and quartile 4 (Q4), from 7 to 10 points. 
A higher BODE index score indicates a greater probability 
of patient mortality.8
Activities of Daily Living Assessment 
The activities that involved effort of the UL and LL 
included brushing teeth, combing hair, taking a shower and 
drying off, putting on shoes, lifting and lowering containers 
to a shelf at eye level, lifting and lowering containers to a 
shelf above the height of the scapula, hanging clothes on a 
clothesline, and sweeping. These activities were simulated 
in the same manner as performed at home. The order of the 
activities was determined randomly during the evaluation, 
and each individual was asked only to complete the task. The 
task times were not pre-determined, with the exception of 
the six-minute duration for sweeping. The container lifting 
activities were adapted from the methodology of Velloso et 
al. 4
The interval between each task lasted from three to five 
minutes or until the variables studied returned to baseline. 
Variables monitored for each ADL were SpO2 using a pulse 
oximeter (Oxypleth® DX2405), heart rate (HR) using a 
frequency meter (Polar®), and sensation of dyspnea using 
the Modified Borg Scale - CR10. Blood pressure (BP) was 
also verified by sphygmomanometer (BD®) and stethoscope 
(Littmann®). All variables were recorded at rest at the end 
of each activity and during the interval between activities. 
The activities were simulated without the collection of 
gases two days before the beginning of the test in order to 
eliminate any learning curve effect. 
Six Minute Walking Test in a Hallway and on a Tread-
mill
The 6MWT was conducted in a flat corridor measuring 
30 m in length. The patients walked unaccompanied during 
the test,14,19,20 but were given verbal encouragement at 
standardized one minute intervals.19 
The 6MWTT was conducted on a treadmill (Inbramed®) 
at a pre-established velocity in Km/h in accordance with 
the tolerance of each subject 9 and with the same standards 
used for the 6MWT. Two tests were performed on alternate 
days to eliminate the effect of any learning curve. SpO2, HR, 
sensation of dyspnea, and BP at rest were monitored during 
both tests.
Sit-To-Stand Test
The Sit-to-Stand Test has been recommended as 
an alternative to indirectly measure LL strength and is 
considered as a predictor of severity by Ozalevli et al.10 In 
this study, a chair with a seat height of 46cm and no arm 
supports was utilized. The patients were instructed to keep 
their UL at their waist and sit down and get up from the chair 
while holding their backs straight and feet supported by the 
floor for a period of two minutes, in accordance with the 
methodology described by Ozalevli et al.10
The patients were provided with pre-established verbal 
encouragement each minute. In addition, measurements were 
obtained for SpO2, HR, sensation of dyspnea, and BP both at 
rest and during the test. 
Evaluation of UL Muscle Strength 
Measurement of the isometric muscular force of the 
UL was obtained from the amount of hand grip strength 
measured by a Jamar® manual dynamometer in force per 
kilogram (kgf), which is recommended by the American 
Society of Hand Therapists (ASHT).21 In the protocol 
utilized, measurements were first obtained for the dominant 
upper limb, followed by measurements of the non-dominant 
limb.22 The measurements were taken in sitting and standing 
postures at the following four angles: seated with the arms 
parallel to the trunk, with the elbow bent at 90o and the 
forearm and wrist in a neutral position, and in an orthostatic 
posture with the upper limb positioned by a goniometer at 
angles of 0o, 90o, and 135o, the same angles used during the 
ADL evaluation. Five Maximum Voluntary Contractions 
(MVC) were performed with a rest interval between each 
of 30 sec.20 The mean of the repetitions for each limb was 
used for statistical analysis based on the reference values 
described by Mathiowetz et al.11, 22 
Analysis of Gases
Respiratory gas collection was performed during ADL, 
6MWTT, and STST using a VO2000 Metabolic System 
(MedGraphics®). The system measured micro-samples 
of the mean of expired gases collected every 20 sec. The 
data produced were digitalized in real time: V
•
E= volume 
of air expired in liters per min. expressed in BTPS (Body 
Temperature, Pressure, Saturated), V
•
O2= volume of oxygen 986
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consumption in liters per min. expressed in STPD (Standard 
Temperature and Pressure Dry), and V
•
CO2= carbonic gas 
consumption in liters per min. expressed in STPD.20,23 
A pneumotachometer with bidirectional flow (low flow) 
was coupled to a face mask. Before the test, the patients 
remained seated for placement of the mask and adaptation 
to the system. 
Statistical Analyses
The Shapiro Wilk Statistical Test was utilized to verify 
the normality of the data expressed as the mean ± standard 
deviation, minimal and maximal values. To evaluate the 
correlation between variables, the Pearson and Spearman 
coefficients were utilized for parametric and non-parametric 
variables respectively. Statistical analyses were performed 
using SPSS software (release 13.0 for Windows), and the 
GraphPad StatMate software program was used to calculate 
the power. p<0.05 was considered as statistically significant.
 
RESULTS
Anthropometric  values,  pulmonary  function 
characteristics, respiratory frequency values at rest, and 
MBQ and BODE Index (Total score) values – for which 
three patients scored in Q1 and seven scored in Q2 – are 
shown in table 1.
The data presented in table 2 show that there was no 
correlation between the BODE Index (Total Score) and the 
V
•
E, V
•
O2, and V
•
CO2 variables in the assessment of ADL or 
the walking speed in the 6MWTT. A negative correlation 
was found, however, between the BODE Index and the 
DW in 6MWTT (r = -0.86), the number of repetitions in 
STST (r = -0.66), the muscle strength for Upper Right Limb 
(URL) and Upper Left Limb (ULL) in the seated (r = -0.83) 
and standing 90o (r = -0.76) positions, and the URL in the 
standing position at 135o (r = -0.76). 
DISCUSSION
COPD is a systemic disease in which different 
factors determine its prognosis such as physical exercise 
intolerance24-28 associated with limitations of the ventilatory 
system and gas exchange and dysfunction of the peripheral 
skeletal musculature of the UL and LL.1, 2 
In accordance with the reference values described 
by Mathiowetz et al.,22 our patients presented relatively 
weak UL musculature, differing from the results found 
by Dourado,29 but this assessment did not impede the 
individuals from performing the ADL tasks. This observation 
was likely due to the predominant use of the UL in the 
performance of ADL and the large number of scapular 
muscles responsible for the elevation of the UL, which 
concomitantly participate in respiratory movements during 
forced respiration. The performance of ADL is important for 
the maintenance of the muscular strength of these limbs30,31 
by reducing impairment of the peripheral musculature as a 
consequence of disuse.
With regard to peripheral muscle impairment, some 
authors state that there is a relationship between low BMI 
and such impairment, with a consequent reduction of 
Table 1 - Anthropometric and Pulmonary Function Characteristics, Modi-
fied Baecke Questionnaire, and BODE Index of the patients evaluated 
 
Variables Mean ± SD Min-Max Values
Age (years) 71.00±7.63 58.00 – 80.00
Weight (kg) 70.67±9.36 48.00 – 84.00
Height (m) 165.80±5.05 155.50 – 172.00
BMI (kg/m2) 25.68±2.76 19.98 – 28.58
FEV1 (% predicted) 45.83±14.25 24.20 – 67.00
FVC (% predicted) 77.45±16.11 59.64 – 103.20
FEV1/FVC (% predicted) 44.70±11.84 28.40 – 65.90
MVV (% predicted) 50.43±17.84 18.00 – 71.00
RF at rest (rpm) 18.00±2.34 13.00 – 22.00
MBQ 8.06±4.66 2.11 – 15.45
BODE Index (total score) 2.80±1.03 1.00 – 4.00
SD= Standard Deviation; BMI= Body mass Index; FEV1= Forced Expira-
tory Volume in the First Second; FVC= Forced Vital Capacity; FEV1/FVC= 
FEV1/FVC ratio; MVV= Maximum Voluntary Ventilation; RF= Respiratory 
Frequency; MBQ= Modified Baecke Questionnaire; BODE Index = Body 
Mass Index, Airflow Obstruction, Dyspnea and Exercise Capacity Index. 
Table 2 - Correlation between the BODE Index and the 
Variables Studied
r p
Dependent Variable Independent 
Variable
BODE Index
Variables ADL (
•
VE,  
•
VO2,  
•
VCO2) ---- > 0.05
Speed 6MWTT ---- > 0.05
DW 6MWTT -0.86 < 0.05*
Number of Repetitions STST -0.66 < 0.04 †
HG URL
Sitting  -0.83  < 0.00 ††
Standing 90o -0.76 < 0.02 †
Standing 135o  -0.76 < 0.02 †
HG ULL
Sitting -0.83  < 0.00 ††
Standing 90o -0.76 < 0.02 †
Pearson: * p<0.05. Spearman: †p< 0.05; ††p<0.01. BODE Index = Body 
Mass Index, Airflow Obstruction, Dyspnea and Exercise Capacity Index; 
ADL= Activities of Daily Living;  
•
VE= Pulmonary Ventilation;  
•
VO2= Oxygen 
Consumption;  
•
VCO2= Carbon Dioxide Production; 6MWTT= Six-Minute 
Treadmill Walking Test; TSTS= Sit-To-Stand-Test; HG= Hand Grip; URL= 
Upper Right Limb; ULL= Upper Left Limb.987
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exercise capacity in patients with COPD.32-34 This suggests 
that when an individual presents with a low BMI, it can 
be due not only to a reduction in muscle mass, but also to 
nutritional depletion, which results in low energy reserves 
that limit the execution of activities.35 In the present study, 
however, the patients presented peripheral muscle weakness 
in the UL, but the majority also had a normal BMI. These 
results support the idea that BMI may not adequately 
identify the loss of muscle mass in patients with COPD.36,37 
Other factors that may be associated with a weak UL 
musculature include prolonged use of corticosteroids, which, 
according to Dourado, cause protein degradation.38
Muscular limitations that functionally incapacitate the 
performance of the proposed ADL and the LL tests were 
not verified. 
In the current study, the BODE Index for patients 
with COPD presented a maximum of 4 points in the total 
score due to impaired pulmonary function and a lower 
tolerance for physical exercise. This was verified by the 
values obtained for FEV1 and DW in the 6MWT and is in 
agreement with Pitta et al.39 and Celli et al.,8 who cite the 
BODE Index as a predictor of disease severity that indirectly 
evaluates exercise capacity and mortality risk. The score 
of 4 observed in our COPD population classified them as 
low mortality risk, in support of our other results presented 
herein. 
With regard to the correlations found, the BODE Index 
was negatively correlated with DW in the 6MWTT, the 
number of repetitions in STST, and the HGT. These results 
suggest that a lower BODE Index score indicates greater 
hand grip strength, greater DW in 6MWTT, and a greater 
number of repetitions in STST. Having demonstrated a 
correlation of the predictor of severity with functional 
performance in both the LL and UL tests as carried out for 
the performance of ADL by patients with COPD suggests 
that these tests are also good predictors of the functional 
assessment when related to the BODE Index, corroborating 
Ozalevli et al.10
Results for DW in 6MWT and 6MWTT revealed a 
strong positive correlation between the tests and both 
tests displayed a strong positive correlation with HGT, 
corroborating previous studies.14,40,41 Moreover, while HGT 
is a direct measurement of peripheral muscle strength in 
the hand and UL, it was also found to be a predictor of DW 
in 6MWTC in patients with COPD and in healthy elderly 
individuals, strengthening the hypothesis that hand grip 
strength is a good predictor of mortality that may later be 
integrated into the BODE Index. 
The results found in this study support the influence 
of HGT in DW, as previously verified by Dourado et al.40 
Although we found no correlation with the number of 
repetitions in STST, corroborating findings by Ozalevli et 
al.,10 the HGT has been considered as a good predictor of the 
functional status of patients with COPD.
It is important to note that the difficulties and limitations 
encountered in our study were related to the choice of 
activities evaluated, the execution time of each activity, the 
predominance of patients with moderate obstruction, and the 
metabolic system utilized, without a telemetry system, all 
reflecting the need to review whether the methods employed 
were the best form of evaluation and suggesting further 
studies on this topic. 
CONCLUSION
In conclusion, this study does not support the hypothesis 
that there is a correlation between the BODE Index and 
ventilatory and metabolic responses during the performance 
of ADL. However, these data do support the hypothesis 
that there is a correlation between the BODE Index and 
the variables assessed in the 6MWTT, STST, and HGT in 
moderate to very severe COPD patients, suggesting their use 
in a predictive index of physical exercise capacity, perhaps 
used as a complement to the BODE Index. However, we did 
not assess whether these results hold true for patients with a 
mild obstruction.
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